Results 271 to 280 of about 2,347,137 (336)

Label‐Free Microscale Technologies for Isolation of Heterogeneous Circulating Tumor Cells

open access: yesAdvanced NanoBiomed Research, EarlyView.
The isolation of circulating tumor cells (CTCs) from liquid biopsy samples is crucial for cancer treatment and monitoring. This review evaluates primary label‐free isolation methods for capturing heterogeneous CTCs and examines their potential to provide deeper insights into tumor heterogeneity and dynamics of cancer progression.
Gürhan Özkayar   +5 more
wiley   +1 more source

Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccine. [PDF]

open access: yesmSphere
Borrow R   +9 more
europepmc   +1 more source

Roadmap to Nanomedical Applications: Nanotoxicology and In Vitro Guidelines for Lanthanide‐Doped Luminescence Nanothermometers

open access: yesAdvanced NanoBiomed Research, EarlyView.
Lanthanide‐based luminescence nanothermometry holds multifaceted potential for nanomedical applications, yet despite significant research advances, clinical translation of the engineered nanomaterials is still controversial and widely disputed. This is related to crucial nanotoxicological aspects that must be addressed at the preclinical level ...
Simona Premcheska   +2 more
wiley   +1 more source

Functional Silver‐Loaded Porous Composite Scaffold for Bone Tissue Bacterial Infection

open access: yesAdvanced NanoBiomed Research, EarlyView.
In the current study, a AgNP‐loaded gelatin/β‐tricalcium phosphate composite scaffold was developed. Its interconnected porous structure facilitated cell adhesion and proliferation while enhancing osteogenic differentiation‐related gene expression to support bone regeneration.
An'nan Hu, Jian Zhou
wiley   +1 more source

Tertiary Lymphoid Organs Are Associated With Bacterial Dysbiosis in Chronic Rhinosinusitis

open access: yes
International Forum of Allergy &Rhinology, EarlyView.
Sathish Paramasivan   +9 more
wiley   +1 more source

Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery Platforms

open access: yesAdvanced NanoBiomed Research, EarlyView.
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy